USPTO 2015–2025 USPTO PatentsView US Corporation

THE Scripps Research Institute

USPTO PatentsView assignee record - 400 granted patents across 40 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

400

Total patents granted

CPC technology areas

15.2

Avg claims per patent

-3%

5-year filing velocity

The verdict

THE holds 400 US patents across 40 technology areas, rank #1,077 of 50,000 tracked assignees.

#1,077
of 50,000 US assignees by volume: Top 7%
by Innovation Score (55.6/100): 15.2
avg claims per patent: -3%
filing velocity, last 5 yrs

Portfolio overview

THE Scripps Research Institute has been granted 400 US utility patents between 2015 and 2025, placing THE Scripps Research Institute at rank #1,077 across all assignees tracked by PlainPatent. This portfolio spans 40 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.2 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, THE Scripps Research Institute is one of the more focused assignees in the PatentsView dataset. By volume, THE sits between Dow Silicones Corporation (402 patents, rank #1,073) and Digital Global Systems, Inc. (396 patents, rank #1,081) - the closest US assignees by grant volume. The composite Innovation Score of 55.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 197 grants, compared with 203 in the 2015–2019 window, a -3% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. THE Scripps Research Institute's 15.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 40 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark THE Scripps Research Institute against peers pursuing similar technology classes.

Dow Silicones

402
Electrolux HOME P…

401
Fisher-rosemount…

401
Ubtech Robotics

401
THE Scripps Resea… ◀

400
Indiana Universit…

399
Mstar Semiconduct…

399
Solaredge

399
Digital Global Sy…

396

What this shows THE holds 400 patents at rank #1,077, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near THE

By rank, the assignees closest to #1,077 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in THE's primary technology class.

THE's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

56 Top 7% higher than 93% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

THE Scripps Research Institute patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	37	9.3%
2016	26	6.5%
2017	56	14.0%
2018	41	10.3%
2019	43	10.8%
2020	58	14.5%
2021	42	10.5%
2022	30	7.5%
2023	25	6.3%
2024	19	4.8%
2025	23	5.8%

Which technologies does THE Scripps Research Institute patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 231

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 227

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 140

C07D - HETEROCYCLIC COMPOUNDS 135

C07K - PEPTIDES 134

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 48

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 48

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 26

C12Y - ENZYMES 20

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 20

C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM 15

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 15

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 15

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 14

C07B - GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 13

Top 15 of 40 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#1,077

Across all tracked assignees

Innovation Score

55.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does THE Scripps Research Institute hold?

THE Scripps Research Institute holds 400 US granted patents filed between 2015 and 2025, spanning 40 technology areas.

What is THE Scripps Research Institute's Innovation Score?

THE Scripps Research Institute has an Innovation Score of 55.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does THE Scripps Research Institute focus on?

THE Scripps Research Institute's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 231 patents. The company has filed patents in 40 CPC subclasses total.

Is THE Scripps Research Institute's patent filing rate increasing or decreasing?

THE Scripps Research Institute's recent filing velocity is -3% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for THE Scripps Research Institute's patents?

THE Scripps Research Institute's patents average 15.2 claims each. This falls within the standard range, providing solid legal coverage.

How is the THE Scripps Research Institute patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

THE's 400 grants land it in the top 7% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - THE ranks #1,077 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.